Analysis Of Income And Expense [Abstract]

European Medical Solutions - Filing #3149844

Concept	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Finance income (cost)	292,000 EUR	271,000 EUR
Other operating income (expense)	5 090 EUR	232,000 EUR
Expenses by nature [abstract]
Raw materials and consumables used	22 662 EUR	22 459 EUR
Services expense	5 309 EUR	4 931 EUR
Classes of employee benefits expense [abstract]
Employee benefits expense	6 438 EUR	6 353 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation expense	696,000 EUR	775,000 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss	1 441 EUR	1 158 EUR
Other expenses, by nature	257,000 EUR	264,000 EUR
Disclosure of attribution of expenses by nature to their function [text block]	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	5 514 EUR	258,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	5 508 EUR	258,000 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	6,000 EUR	0 EUR